Cwm LLC Has $55.42 Million Stock Position in UnitedHealth Group Incorporated $UNH

Cwm LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 20.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 160,487 shares of the healthcare conglomerate’s stock after buying an additional 27,026 shares during the period. Cwm LLC’s holdings in UnitedHealth Group were worth $55,416,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Pacer Advisors Inc. lifted its stake in UnitedHealth Group by 27.8% in the third quarter. Pacer Advisors Inc. now owns 95,038 shares of the healthcare conglomerate’s stock valued at $32,817,000 after buying an additional 20,702 shares during the period. Clayton Financial Group LLC acquired a new position in shares of UnitedHealth Group during the 3rd quarter valued at $74,000. Blue Zone Wealth Advisors LLC grew its holdings in UnitedHealth Group by 6.1% in the third quarter. Blue Zone Wealth Advisors LLC now owns 26,250 shares of the healthcare conglomerate’s stock worth $9,064,000 after purchasing an additional 1,511 shares during the period. Johnson & White Wealth Management LLC grew its stake in shares of UnitedHealth Group by 65.0% in the 3rd quarter. Johnson & White Wealth Management LLC now owns 3,494 shares of the healthcare conglomerate’s stock valued at $1,206,000 after buying an additional 1,376 shares during the period. Finally, Whitener Capital Management Inc. acquired a new position in UnitedHealth Group during the 3rd quarter worth approximately $227,000. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the topic of a number of recent research reports. Wells Fargo & Company raised their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Jefferies Financial Group lifted their price target on UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a research note on Friday, October 17th. Morgan Stanley raised their target price on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. UBS Group upped their price target on UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a report on Wednesday, October 29th. Finally, Zacks Research raised shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Seventeen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $385.54.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $327.08 on Friday. The firm has a market capitalization of $296.28 billion, a PE ratio of 17.07, a P/E/G ratio of 2.13 and a beta of 0.43. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The company has a 50-day moving average price of $334.20 and a two-hundred day moving average price of $318.80. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $606.36.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same period in the previous year, the company posted $7.15 EPS. The firm’s revenue for the quarter was up 12.2% compared to the same quarter last year. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were paid a $2.21 dividend. The ex-dividend date was Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.7%. UnitedHealth Group’s dividend payout ratio is currently 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.